Japan can­cels 140M dose or­der for No­vavax Covid vac­cine amid 'low­er than ex­pect­ed' de­mand

Japan has can­celed an or­der for more than 140 mil­lion dos­es of No­vavax’s Covid-19 vac­cine, Take­da re­vealed in an SEC fil­ing.

The coun­try ini­tial­ly agreed in 2021 to pur­chase 150 mil­lion dos­es of the vac­cine from Take­da, which has been pro­duc­ing No­vavax’s vac­cine at its Hikari-based fa­cil­i­ty. But af­ter on­ly pur­chas­ing 8.24 mil­lion dos­es, the Min­istry of Health, Labour and Wel­fare has can­celed the re­main­ing 141.76 mil­lion dos­es.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER